Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Recall on Ther-Rx Brand Iron Supplements
Ther-Rx Corporation, a subsidiary of KV Pharmaceutical, has recalled all lots of Ther-Rx brand IRON SUPPLEMENT PRODUCTS. These recalled tablets, caplets, and capsules may have been manufactured under conditions that did not meet the current manufacturing standards called Good Manufacturing Practices (cGMPs). Ther-Rx is recalling all of their products to ensure that defective products are not available to patients. The Ther-Rx products involved in the recall are listed below: Chromagen Caplet Chromagen FA Caplet Chromagen Forte Caplet Encora Capsule Niferex Gold Tablet Niferex 150 Forte Capsule Repliva 21/7 Tablet For more information, please visit:
Learn More

Nycomed Recalls Select Lots of Omnaris (ciclesonide) Nasal Spray, 50mcg
Nycomed has recalled select lots of Omnaris (ciclesonide) Nasal Spray, 50mcg. Lot number 138305 has been recalled because these lots failed the routine stability tests performed by the manufacturer. Omnaris contains the active ingredient ciclesonide and is commonly used in the treatment of allergies. This recall alert only applies to the select lots of Omnaris (ciclesonide) Nasal Spray, 50mcg. No other ciclesonide products were involved in this recall. To view the FDA notice about this recall, please visit:
Learn More

Date Published Title Drug Source
2009-02-05 Recall on Ther-Rx Brand Iron Supplements Chromagen Manufacturer
2011-12-22 Nycomed Recalls Select Lots of Omnaris (ciclesonide) Nasal Spray, 50mcg Ciclesonide Nasal FDA
2012-05-21 Sunovion Pharmaceuticals Recalls a Single Lot of Omnaris (ciclesonide) Nasal Spray 50 mcg Ciclesonide Nasal FDA
2012-02-02 Paddock Laboratories, Inc. Recalls Select Lots of Ciclopirox Gel 0.77% Ciclopirox FDA
2008-08-04 Generic Manufacturer Recalls Several Drug Products Cilostazol Manufacturer
2009-04-10 National Recall of Pharmaceutical Associates, Inc. Brand Cimetidine Oral Solution Cimetidine Manufacturer
2008-07-08 Increased risk of tendinitis and tendon rupture Ciprofloxacin FDA
2008-09-18 FDA Stops Imports of Ranbaxy Products Ciprofloxacin FDA
2009-01-12 New Antidepressant Guide for Patients Citalopram FDA
2009-07-10 Recall of Two Lots of Citalopram: One Lot of 10 mg Tablets and One Lot of 40 mg Tablets Citalopram FDA
2009-09-30 Recall of Single Lot of Dr. Reddy's Citalopram 40 mg Tablets Citalopram Manufacturer
2011-03-28 Possible Label Switch Prompts Recall of Generic Citalopram 10mg and Finasteride 5mg Citalopram FDA
2011-08-27 Abnormal Heart Rhythms Associated with High Doses of Citalopram (Celexa) Citalopram FDA
2012-03-28 FDA Revises Recommendations for Citalopram (Celexa) Related to a Potential Risk of Abnormal Heart Rhythms Citalopram FDA
2014-02-20 Manufacturer Recalls Specific Lots of L-Citrulline After Reports of Adverse Events Citrulline FDA
2008-09-18 FDA Stops Imports of Ranbaxy Products Clarithromycin FDA
2009-01-29 Recall on Ther-Rx Brand Clindesse Clindamycin Manufacturer
2013-12-03 FDA Warns of Risk of Serious Skin Reactions with Onfi (Clobazam) Clobazam FDA
2008-09-03 Statins plus fibrates increase risk of muscle problems Clofibrate MediGuard CRT
2008-12-17 New FDA Warning on Seizure Medications Clonazepam FDA
Back to Consumer Med Safety